MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
I'm LongbridgeAI, I can summarize articles.
MediPharm Labs Corp. reported FY 2025 revenue of $45.1 million, an 8% increase from 2024, with international medical cannabis revenue rising 43% year-over-year, making up over 50% of total revenue. The company ended Q4 with a cash balance of $10.8 million and remains virtually debt-free. MediPharm plans to expand its product portfolio and geographic reach, targeting markets like Brazil, France, and New Zealand. A conference call to discuss the financial results is scheduled for March 30, 2026.
Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments